Saved in:
| Title: | Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / |
|---|---|
| From: |
edited by Arnold von Eckardstein, Christoph J. Binder.
|
| Person: |
von Eckardstein, Arnold.
Binder, Christoph J. editor. |
| Corporate Author: | |
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2022.
|
| Edition: | 1st ed. 2022. |
| Series: | Handbook of Experimental Pharmacology,
270 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-030-86076-9 |
| Summary: | This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. . |
| Physical Description: | 1 Online-Ressource (X, 538 p. 40 illus., 37 illus. in color.) |
| ISBN: | 9783030860769 |
| ISSN: | 1865-0325 ; |
| Access: | Open Access |
Staff View
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | ZDB-2-SBL-978-3-030-86076-9 | ||
| 003 | DE-He213 | ||
| 005 | 20240318082951.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220131s2022 sz | o |||| 0|eng d | ||
| 020 | |a 9783030860769 |9 978-3-030-86076-9 | ||
| 024 | 7 | |a 10.1007/978-3-030-86076-9 |2 doi | |
| 050 | 4 | |a RC1-1245 | |
| 050 | 4 | |a RC1-1245 | |
| 072 | 7 | |a MJ |2 bicssc | |
| 072 | 7 | |a MJ |2 bicssc | |
| 072 | 7 | |a MED045000 |2 bisacsh | |
| 072 | 7 | |a MJ |2 thema | |
| 072 | 7 | |a MJ |2 thema | |
| 082 | 7 | |a 616 |2 23 | |
| 082 | 7 | |a 616 |2 23 | |
| 245 | 1 | 0 | |a Prevention and Treatment of Atherosclerosis |h [electronic resource] : |b Improving State-of-the-Art Management and Search for Novel Targets / |c edited by Arnold von Eckardstein, Christoph J. Binder. |
| 250 | |a 1st ed. 2022. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2022. | |
| 300 | |a 1 Online-Ressource (X, 538 p. 40 illus., 37 illus. in color.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 270 | |
| 505 | 0 | |a Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. | |
| 506 | 0 | |a Open Access | |
| 520 | |a This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. . | ||
| 650 | 0 | |a Internal medicine. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Diseases. | |
| 650 | 1 | 4 | |a Internal Medicine. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Internal Medicine. |
| 650 | 2 | 4 | |a Diseases. |
| 700 | 1 | |a von Eckardstein, Arnold. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Binder, Christoph J. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783030860752 |
| 776 | 0 | 8 | |i Printed edition: |z 9783030860776 |
| 776 | 0 | 8 | |i Printed edition: |z 9783030860783 |
| 830 | 0 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 270 | |
| 966 | 4 | 0 | |l DE-355 |p ZDB-2-SBL |q UBG_PDA_SBL |u https://doi.org/10.1007/978-3-030-86076-9 |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 912 | |a ZDB-2-SOB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 912 | |a ZDB-2-SBL | ||
| 049 | |a DE-355 | ||
Record in the Search Index
| DE-BY-UBR_katkey | ZDB-2-SBL-978-3-030-86076-9 |
|---|---|
| _version_ | 1835726564132651008 |
| adam_text | |
| any_adam_object | |
| author2 | von Eckardstein, Arnold Binder, Christoph J. |
| author2_role | edt edt |
| author2_variant | e a v ea eav c j b cj cjb |
| author_corporate | SpringerLink (Online service) |
| author_corporate_role | |
| author_facet | von Eckardstein, Arnold Binder, Christoph J. SpringerLink (Online service) |
| building | Verbundindex |
| bvnumber | localUBR |
| callnumber-first | R - Medicine |
| callnumber-label | RC1-1245 |
| callnumber-raw | RC1-1245 |
| callnumber-search | RC1-1245 |
| callnumber-sort | RC 11 41245 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-2-SBL ZDB-2-SXB ZDB-2-SOB |
| contents | Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. |
| dewey-full | 616 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616 |
| dewey-search | 616 |
| dewey-sort | 3616 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1st ed. 2022. |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03388nam a22006135i 4500</leader><controlfield tag="001">ZDB-2-SBL-978-3-030-86076-9</controlfield><controlfield tag="003">DE-He213</controlfield><controlfield tag="005">20240318082951.0</controlfield><controlfield tag="007">cr nn 008mamaa</controlfield><controlfield tag="008">220131s2022 sz | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030860769</subfield><subfield code="9">978-3-030-86076-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-86076-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC1-1245</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC1-1245</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">thema</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevention and Treatment of Atherosclerosis</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Improving State-of-the-Art Management and Search for Novel Targets /</subfield><subfield code="c">edited by Arnold von Eckardstein, Christoph J. Binder.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2022.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 538 p. 40 illus., 37 illus. in color.) </subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">270</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="a">Open Access</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Internal medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diseases.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Internal Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Internal Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Diseases.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Eckardstein, Arnold.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Binder, Christoph J.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">SpringerLink (Online service)</subfield></datafield><datafield tag="773" ind1="0" ind2=" "><subfield code="t">Springer Nature eBook</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783030860752</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783030860776</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783030860783</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">270</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">UBG_PDA_SBL</subfield><subfield code="u">https://doi.org/10.1007/978-3-030-86076-9</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SXB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SOB</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (SpringerNature-11642)</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (R0) (SpringerNature-43708)</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield></record></collection> |
| id | ZDB-2-SBL-978-3-030-86076-9 |
| illustrated | Not Illustrated |
| indexdate | 2025-06-23T13:27:56Z |
| institution | BVB |
| isbn | 9783030860769 |
| issn | 1865-0325 ; |
| language | English |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (X, 538 p. 40 illus., 37 illus. in color.) |
| psigel | ZDB-2-SBL UBG_PDA_SBL ZDB-2-SBL ZDB-2-SXB ZDB-2-SOB |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Springer International Publishing : Imprint: Springer, |
| record_format | marc |
| series | Handbook of Experimental Pharmacology, |
| series2 | Handbook of Experimental Pharmacology, |
| spelling | Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. 1st ed. 2022. Cham : Springer International Publishing : Imprint: Springer, 2022. 1 Online-Ressource (X, 538 p. 40 illus., 37 illus. in color.) text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Handbook of Experimental Pharmacology, 1865-0325 ; 270 Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. Open Access This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. . Internal medicine. Pharmacology. Diseases. Internal Medicine. von Eckardstein, Arnold. editor. edt http://id.loc.gov/vocabulary/relators/edt Binder, Christoph J. editor. edt http://id.loc.gov/vocabulary/relators/edt SpringerLink (Online service) Springer Nature eBook Printed edition: 9783030860752 Printed edition: 9783030860776 Printed edition: 9783030860783 |
| spellingShingle | Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / Handbook of Experimental Pharmacology, Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. Internal medicine. Pharmacology. Diseases. Internal Medicine. |
| title | Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / |
| title_auth | Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / |
| title_exact_search | Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets / |
| title_full | Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. |
| title_fullStr | Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. |
| title_full_unstemmed | Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder. |
| title_short | Prevention and Treatment of Atherosclerosis |
| title_sort | prevention and treatment of atherosclerosis improving state of the art management and search for novel targets |
| title_sub | Improving State-of-the-Art Management and Search for Novel Targets / |
| topic | Internal medicine. Pharmacology. Diseases. Internal Medicine. |
| topic_facet | Internal medicine. Pharmacology. Diseases. Internal Medicine. |
| work_keys_str_mv | AT voneckardsteinarnold preventionandtreatmentofatherosclerosisimprovingstateoftheartmanagementandsearchfornoveltargets AT binderchristophj preventionandtreatmentofatherosclerosisimprovingstateoftheartmanagementandsearchfornoveltargets AT springerlinkonlineservice preventionandtreatmentofatherosclerosisimprovingstateoftheartmanagementandsearchfornoveltargets |